Search research articles
Contact Us
Filters
Showing results (461-470 of 471) with videos related to
Page
of 48
Sort By:
Clinical Lymphoma, Myeloma & Leukemia
|
April 1, 2023
Response to COVID-19 Vaccination Post-CAR T Therapy in Patients With Non-Hodgkin Lymphoma and Multiple Myeloma
Julia E Wiedmeier-Nutor, Madiha Iqbal, Allison C Rosenthal, et al.
Bone Marrow Transplantation
|
July 11, 2018
Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement
Wilson I Gonsalves, Francis K Buadi, Sikander Ailawadhi, et al.
American Journal of Hematology
|
December 10, 2019
Impact of MYD88<sup>L265P</sup> mutation status on histological transformation of Waldenström Macroglobulinemia
Saurabh Zanwar, Jithma P Abeykoon, Eric Durot, et al.
Mayo Clinic Proceedings
|
August 13, 2010
Diagnosis and management of Waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines
Stephen M Ansell, Robert A Kyle, Craig B Reeder, et al.
Blood Advances
|
February 17, 2022
Clinical activity of single-dose systemic oncolytic VSV virotherapy in patients with relapsed refractory T-cell lymphoma
Joselle Cook, Kah-Whye Peng, Thomas E Witzig, et al.
Mayo Clinic Proceedings
|
June 5, 2021
Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement 2020 Update
Eli Muchtar, Angela Dispenzieri, Morie A Gertz, et al.
Blood Advances
|
April 22, 2026
A multi-center study of progression-risk and outcomes in solitary bone plasmacytoma with and without marrow involvement
Kenneth Jc Lim, Maximilian Johannes Steinhardt, Matthew J Rees, et al.
JAMA Oncology
|
January 6, 2017
Diagnosis and Management of Waldenström Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines 2016
Prashant Kapoor, Stephen M Ansell, Rafael Fonseca, et al.
American Journal of Hematology
|
June 9, 2026
Therapeutic Outcomes in VEXAS Syndrome: A Multicenter Comparative Cohort of Allogeneic Hematopoietic Stem Cell Transplantation and Hypomethylating Agents
Saubia Fathima, Margaret Mei-Kay Wong, Jesus Gonzalez-Lugo, et al.
The New England Journal of Medicine
|
August 22, 2019
Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma
Ajai Chari, Dan T Vogl, Maria Gavriatopoulou, et al.
Page
of 48
Search research articles
Search
Showing results (461-470 of 471) with videos related to
Sort By:
Page
of 48
Clinical Lymphoma, Myeloma & Leukemia
|
April 1, 2023
Response to COVID-19 Vaccination Post-CAR T Therapy in Patients With Non-Hodgkin Lymphoma and Multiple Myeloma
Julia E Wiedmeier-Nutor, Madiha Iqbal, Allison C Rosenthal, et al.
Bone Marrow Transplantation
|
July 11, 2018
Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement
Wilson I Gonsalves, Francis K Buadi, Sikander Ailawadhi, et al.
American Journal of Hematology
|
December 10, 2019
Impact of MYD88<sup>L265P</sup> mutation status on histological transformation of Waldenström Macroglobulinemia
Saurabh Zanwar, Jithma P Abeykoon, Eric Durot, et al.
Mayo Clinic Proceedings
|
August 13, 2010
Diagnosis and management of Waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines
Stephen M Ansell, Robert A Kyle, Craig B Reeder, et al.
Blood Advances
|
February 17, 2022
Clinical activity of single-dose systemic oncolytic VSV virotherapy in patients with relapsed refractory T-cell lymphoma
Joselle Cook, Kah-Whye Peng, Thomas E Witzig, et al.
Mayo Clinic Proceedings
|
June 5, 2021
Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement 2020 Update
Eli Muchtar, Angela Dispenzieri, Morie A Gertz, et al.
Blood Advances
|
April 22, 2026
A multi-center study of progression-risk and outcomes in solitary bone plasmacytoma with and without marrow involvement
Kenneth Jc Lim, Maximilian Johannes Steinhardt, Matthew J Rees, et al.
JAMA Oncology
|
January 6, 2017
Diagnosis and Management of Waldenström Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines 2016
Prashant Kapoor, Stephen M Ansell, Rafael Fonseca, et al.
American Journal of Hematology
|
June 9, 2026
Therapeutic Outcomes in VEXAS Syndrome: A Multicenter Comparative Cohort of Allogeneic Hematopoietic Stem Cell Transplantation and Hypomethylating Agents
Saubia Fathima, Margaret Mei-Kay Wong, Jesus Gonzalez-Lugo, et al.
The New England Journal of Medicine
|
August 22, 2019
Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma
Ajai Chari, Dan T Vogl, Maria Gavriatopoulou, et al.
Page
of 48